Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBlencowe Resources Regulatory News (BRES)

Share Price Information for Blencowe Resources (BRES)

Share Price is delayed by 15 minutes
Get Live Data
8.10    0.06 (0.75%)
Bid:
7.90
Ask:
8.30
Spread: 0.40 (5.063%)
Market Cap: £39.85m
BRES Live PriceLast checked at - London Stock Exchange

Intraday Blencowe Resources Share Chart

DFS Performance Shares - Replacement

7 Jan 2026 09:17

RNS Number : 9854N
Blencowe Resources PLC
07 January 2026
 

7 January 2026

This is a replacement to RNS 1504N dated 30 December 2025. The date of admission has changed to 12 January 2026 and the total voting rights is now 477,295,645 following admission of the DFS Performance Shares.

 

Blencowe Resources Plc

("Blencowe" or the "Company")

 

Issue of DFS Performance Shares

 

Blencowe Resources Plc (LSE: BRES) announces that it has issued 12,000,000 DFS Performance Shares.

The DFS Performance Options have now vested following the completion and publication of the company's Definitive feasibility Study on 1 December 2025. Accordingly, the Company is now required to issue 12,000,000 new ordinary shares as set out below (the "DFS Performance Shares").

Each holder of the DFS Performance Shares has agreed to a lock up for a period of 12 months from Admission.

Director

DFS Performance shares issued

Current holdings

Holdings on Admission

Holdings % of Enlarged Share Capital

Cameron Pearce

3,000,000

13,016,667

16,016,667

3.4%

Mike Ralston

3,000,000

10,891,666

13,891,666

2.9%

Iain Wearing

3,000,000

10,461,666

13,461,666

2.8%

Lionshead Consultants Ltd *

2,250,000

7,833,334

10,083,334

2.1%

Alex Passmore

750,000

2,816,667

3,566,667

0.7%

* beneficially owned by Sam Quinn

Admission and Total Voting Rights

An application has been made for 12,000,000 Ordinary Shares to be admitted to trading on the Equity (Transition) category of the official list and the main market of the London Stock Exchange from 8.00 a.m. on 12 January 2026 ("Admission").

In accordance with the FCA's Disclosure Guidance and Transparency Rules, the Company confirms that following Admission, the Company's enlarged issued ordinary share capital will comprise 477,295,645 Ordinary Shares. The Company does not hold any Ordinary Shares in Treasury. Therefore, following Admission, the above figure may be used by shareholders in the Company as the denominator for the calculations to determine if they are required to notify their interest in, or a change to their interest in the Company, under the FCA's Disclosure Guidance and Transparency Rules.

 

 

For further information please contact:

 

Blencowe Resources Plc

Sam Quinn

 

www.blencoweresourcesplc.com

Tel: +44 (0)1624 681 250

info@blencoweresourcesplc.com

 

Investor Relations

Sasha Sethi

Tel: +44 (0) 7891 677 441

sasha@flowcomms.com

 

Tavira Financial 

Jonathan Evans

Tel: +44 (0)20 3192 1733

jonathan.evans@tavira.group

 

 

Twitter https://twitter.com/BlencoweRes

LinkedIn https://www.linkedin.com/company/72382491/admin/

 

 

 

 

Appendix

Notification of Transactions by Persons Discharging Managerial Responsibilities and Persons Closely Associated with them

(This form is required for disclosure of transactions under Article 19 of Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse (Market Abuse Regulation)

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

 

1. Cameron Pearce

2. Mike Ralston

3. Iain Wearing

4. Lionshead Consultants (S Quinn)

5. Alexander Passmore

 

 

2

Reason for the notification

a)

Position/status

1. Director

2. Manager

3. Manager

4. Director

5. Director

b)

Initial notification /Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Blencowe Resources PLC

b)

LEI

 

213800UX1HBIRK36GG11

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

 

Identification code

Ordinary shares

 

 

 

GB00BFCMVS34

b)

Nature of the transaction

Exercise of Share options

c)

Price(s) and volume(s)

Price

Volume

1. 0.005

2. 0.005

3. 0.005

4. 0.005

5. 0.005

1. 3,000,000

2. 3,000,000

3. 3,000,000

4. 2,250,000

5. 750,000

d)

Aggregated information

 

- Aggregated volume

 

- Price

 

N/A

 

 

 

£0.005

e)

Date of Transaction

 

 30 December 2025

f)

Place of transaction

London Stock Exchange

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHGCGDBSGGDGLR
Date   Source Headline
23rd Oct 202510:48 amRNSExercise of Warrants
21st Oct 20257:00 amRNSFurther Drilling Results - Camp Lode
17th Oct 202511:08 amRNS-RInterview with CEO Mike Ralston -DFS Progress
17th Oct 20257:00 amRNSFurther Battery Testing Success
15th Oct 20255:00 pmRNSHolding(s) in Company
8th Oct 202512:24 pmRNSExercise of Warrants
3rd Oct 20257:00 amRNSIssue of DFC Performance Shares and DFS Options
1st Oct 20251:19 pmRNSExercise of Warrants
26th Sep 20259:04 amRNSHolding(s) in Company
25th Sep 20257:00 amRNSDrilling Results
23rd Sep 20257:00 amRNSHolding(s) in Company
12th Sep 20257:00 amRNSFundraise of £1.12m and Exercise of Options at 6p
10th Sep 20257:00 amRNS-RUpdated Corporate Presentation
4th Sep 20257:00 amRNSAppointment of Project Finance Adviser
22nd Aug 20257:00 amRNSCompletion of Orom-Cross DFS Programmes
12th Aug 20257:00 amRNSIssue of Equity
1st Aug 20257:00 amRNSOfftake Agreement Signed
30th Jul 20257:00 amRNSExercise of Warrants
17th Jul 20257:00 amRNSStage 7 Drill Program Completed
8th Jul 202510:48 amRNSExercise of Warrants
8th Jul 20257:00 amRNSReceipt of US$0.75 million from DFC
2nd Jul 20257:00 amRNSDeep Drilling at Northern Syncline
26th Jun 20257:00 amRNSStage 7 Drilling Program Update
13th Jun 20257:00 amRNSSAFELOOP Testing Update
2nd Jun 20253:56 pmRNSInterim Consolidated FS Six Month End 31 Mar 2025
23rd May 20257:00 amRNSFurther US$0.5M Grant Funding Received From DFC
22nd May 20259:36 amRNSHolding(s) in Company
21st May 20257:00 amRNS-RInterview with CEO
7th May 20257:00 amRNSStage 7 Drill Program Nears Completion
22nd Apr 20254:43 pmRNSResults of Retail Offer - Replacement
16th Apr 20258:14 amRNSResults of Retail Offer
15th Apr 20254:40 pmRNSRetail Offer to Raise up to £100,000
15th Apr 20254:35 pmRNSFundraise of £1m to support completion of the DFS
8th Apr 20257:39 amRNSOfftake Agreement with TaiDa
31st Mar 20257:00 amRNSDrilling Update
21st Mar 20257:00 amRNSESIA Approval
19th Mar 20257:00 amRNSOfftake for Purified Graphite
3rd Mar 20257:00 amRNSAFC Expression of Interest
26th Feb 20254:32 pmRNSResult of AGM
20th Feb 20257:00 amRNSHydropower Study
14th Feb 20257:00 amRNS7,000m Drilling Programme
31st Jan 20258:56 amRNSAnnual Financial Report
30th Jan 20257:00 amRNSSAFELOOP Update
28th Jan 20257:00 amRNS-RWebinar 25 February 2025
9th Jan 20257:00 amRNSCommencement of Drilling
19th Dec 202411:02 amRNSResult of Meeting
10th Dec 202410:04 amRNS-RUpdated Corporate Presentation
9th Dec 20247:00 amRNSExercise of Warrants
28th Nov 20247:00 amRNSBlencowe Joins European EV Consortium
26th Nov 202412:12 pmRNSPublication of a Prospectus

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.